BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 14680499)

  • 21. Circulating angiogenic growth factor levels in mice bearing human tumors using Luminex Multiplex technology.
    Keyes KA; Mann L; Cox K; Treadway P; Iversen P; Chen YF; Teicher BA
    Cancer Chemother Pharmacol; 2003 Apr; 51(4):321-7. PubMed ID: 12721760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
    Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
    Eur Cytokine Netw; 2001; 12(3):445-52. PubMed ID: 11566625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nipple fluid basic fibroblast growth factor in patients with breast cancer.
    Sartippour MR; Zhang L; Lu M; Wang HJ; Brooks MN
    Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2995-8. PubMed ID: 16365024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum levels of basic fibroblast growth factor and vascular endothelial growth factor in children and adolescents with type 1 diabetes mellitus.
    Malamitsi-Puchner A; Sarandakou A; Tziotis J; Dafogianni C; Bartsocas CS
    Pediatr Res; 1998 Dec; 44(6):873-5. PubMed ID: 9853920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum bFGF (basic fibroblast growth factor) and CA 15.3 in the monitoring of breast cancer patients.
    Pichon MF; Moulin G; Pallud C; Pecking A; Floiras JL
    Anticancer Res; 2000; 20(2B):1189-94. PubMed ID: 10810420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of circulating cytokeratin fragments and angiogenic factors in NSCLC patients stage IIIa-IIIb receiving curatively intended treatment.
    Eriksson P; Brattström D; Hesselius P; Larsson A; Bergström S; Ekman S; Goike H; Wagenius G; Brodin O; Bergqvist M
    Neoplasma; 2006; 53(4):285-90. PubMed ID: 16830054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression of angiogenic factors and their clinical significances in acute myeloid leukemia].
    Wang Y; Xiao ZJ; Liu P; Peng Z; Han ZC
    Ai Zheng; 2004 Nov; 23(11 Suppl):1423-7. PubMed ID: 15566649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiogenic activity in patients with psoriasis is significantly decreased by Goeckerman's therapy.
    Andrys C; Borska L; Pohl D; Fiala Z; Hamakova K; Krejsek J
    Arch Dermatol Res; 2007 Mar; 298(10):479-83. PubMed ID: 17221216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiogenic protein expression in advanced epithelial ovarian cancer.
    Barton DP; Cai A; Wendt K; Young M; Gamero A; De Cesare S
    Clin Cancer Res; 1997 Sep; 3(9):1579-86. PubMed ID: 9815846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum levels of angiogenic factors in early breast cancer remain close to normal.
    Duranyildiz D; Camlica H; Soydinc HO; Derin D; Yasasever V
    Breast; 2009 Feb; 18(1):26-9. PubMed ID: 18996696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zoledronic-acid-induced circulating level modifications of angiogenic factors, metalloproteinases and proinflammatory cytokines in metastatic breast cancer patients.
    Ferretti G; Fabi A; Carlini P; Papaldo P; Cordiali Fei P; Di Cosimo S; Salesi N; Giannarelli D; Alimonti A; Di Cocco B; D'Agosto G; Bordignon V; Trento E; Cognetti F
    Oncology; 2005; 69(1):35-43. PubMed ID: 16088233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum vascular endothelial growth factor (VEGF) levels correlate with tumor VEGF and p53 overexpression in endocrine positive primary breast cancer.
    Iovino F; Ferraraccio F; Orditura M; Antoniol G; Morgillo F; Cascone T; Diadema MR; Aurilio G; Santabarbara G; Ruggiero R; Belli C; Irlandese E; Fasano M; Ciardiello F; Procaccini E; Lo Schiavo F; Catalano G; De Vita F
    Cancer Invest; 2008; 26(3):250-5. PubMed ID: 18317965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiogenic molecule expression is downregulated in effusions from breast cancer patients.
    Konstantinovsky S; Nielsen S; Vyberg M; Kvalheim G; Nesland JM; Reich R; Davidson B
    Breast Cancer Res Treat; 2005 Nov; 94(1):71-80. PubMed ID: 16142438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum endostatin predicts tumor vascularity in hepatocellular carcinoma.
    Dhar DK; Ono T; Yamanoi A; Soda Y; Yamaguchi E; Rahman MA; Kohno H; Nagasue N
    Cancer; 2002 Nov; 95(10):2188-95. PubMed ID: 12412173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiogenic and coagulation-fibrinolysis factors in non Hodgkin's lymphoma.
    Wróbel T; Poreba M; Mazur G; Poreba R; Pyszel A; Beck B; Steinmetz-Beck A; Andrzejak R; Kuliczkowski K
    Neoplasma; 2006; 53(3):253-8. PubMed ID: 16652197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular endothelial growth factor and basic fibroblast growth factor urine levels as predictors of outcome in hormone-refractory prostate cancer patients: a cancer and leukemia group B study.
    Bok RA; Halabi S; Fei DT; Rodriquez CR; Hayes DF; Vogelzang NJ; Kantoff P; Shuman MA; Small EJ
    Cancer Res; 2001 Mar; 61(6):2533-6. PubMed ID: 11289126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coexpression of heparanase, basic fibroblast growth factor and vascular endothelial growth factor in human esophageal carcinomas.
    Mikami S; Ohashi K; Katsube K; Nemoto T; Nakajima M; Okada Y
    Pathol Int; 2004 Aug; 54(8):556-63. PubMed ID: 15260846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma vascular endothelial but not fibroblast growth factor levels correlate with colorectal liver mestastasis vascularity and volume.
    Davies MM; Jonas SK; Kaur S; Allen-Mersh TG
    Br J Cancer; 2000 Mar; 82(5):1004-8. PubMed ID: 10737380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma: a possible diagnostic tool for lymph node metastasis.
    Tamura M; Ohta Y
    Cancer; 2003 Sep; 98(6):1217-22. PubMed ID: 12973845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Difference in expression of VEGF, bFGF and their receptors between the young and postmenopausal women with breast cancer].
    Yi WJ; Tang ZH; Yang ZL; Yu MY; Li YS; Chen GN
    Zhonghua Zhong Liu Za Zhi; 2003 Mar; 25(2):141-4. PubMed ID: 12795839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.